ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Q2 Closes With Earnings Fire, Bears Double Down

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Quarter-End Earnings in Focus

Three S&P 500 names report today, marking the end of Q2. NKE releases Q4 2026 results after the close. Tariff pressures and margin guidance will dominate the call. STZ posts Q1 FY2027 numbers with beer volumes under scrutiny. GIS rounds out the trio with a pre-recorded call this evening. General Mills carries the heaviest short interest of the group at nearly 10% of free float. Options markets are tightly wound around near-term expiries for all three names.

Bears Double Down on Key Names

Short sellers aren't waiting for earnings to make their moves. WOLF now has short interest at 132% of free float — up from 105% just one week ago. Zero share availability confirms no new borrow is available. HTZ shorts jumped from 44.6% to 62.6% in seven days. Bears remain deeply skeptical of any Hertz recovery. AI infrastructure name CRWV also drew fresh shorts, with SI climbing from 22% to 29%.

Analysts Back Chips and Airlines

Wells Fargo made bold calls today. The bank raised its target on AMD by $110 to $615, citing AI chip momentum. It also lifted UAL to $165, keeping a Buy. DIS earned a Buy upgrade from JP Morgan, with analyst David Karnovsky moving his target to $140.

Pharma Catalyst in Europe

ABBV and Danish biotech GMAB delivered a positive headline today. Their lymphoma trial met its main goal. Analysts are already flagging a bigger market opportunity. The trial result is a meaningful win heading into H2.

Stocks in this article

How this article was generated

Generated
30 Jun 2026, 16:50
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensus

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.